Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV

Hepatitis B- and C-virus (HBV and HCV) infections contribute to hepatocellular carcinoma (HCC) development through several different mechanisms. In addition to a diverse molecular background, HCC subtypes also show differences in their metabolic profiles, suggesting that prevention and treatment mig...

Descripción completa

Detalles Bibliográficos
Autores principales: De Matteis, Serena, Ghetti, Martina, Gramantieri, Laura, Marisi, Giorgia, Casadei-Gardini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335550/
https://www.ncbi.nlm.nih.gov/pubmed/34366674
http://dx.doi.org/10.2147/OTT.S312748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335550/
https://www.ncbi.nlm.nih.gov/pubmed/34366674
http://dx.doi.org/10.2147/OTT.S312748

Ejemplares similares